期刊文献+

具有自塑能力可吸收注射型纳米骨浆 被引量:22

BIORESORBABLE SELF-SETTING INJECTABLE NANOBONE PUTTY
下载PDF
导出
摘要 目的 :为研制一种适应整形外科微创技术发展的一种可注射、可吸收、无致热、原位立即变硬的骨替代材料。方法 :通过合成研制一种有缓冲性的粘滞性骨浆 ,在体外研究其生物相容性 ,同时在犬的双侧肱骨缺损模型上研究其自塑形和生物吸收特性。结果 :实验证明这种植入材料具有极好的塑形性能 ,在 12~ 18周内完全吸收 ,临床上治疗骨折的X线显像证实 ,植入物吸收和骨再生存在一个合适的比例。结论 :本文阐述了一种生物可吸收可调节硬化时间的注射性骨浆 ,这种骨浆的特性符合多数骨增生过程 ,具有自动充填 ,不产热 ,即便在潮湿和血运丰富的情况下亦能硬化 ,植入成分被设计为产生中性 pH值的骨浆能重建骨组织 ,不含有聚合体或可塑剂。大量体外研究表明这一材料具有高度生物相容性和非致热源性。 Objective: To develope an injectable, bioresorbable bone substitute that can immediately harden isothermally in situ for meeting developments in minimally invasive techniques for orthopedic surgery.Methods: A buffered viscous bone putty was produce by synthezation; biocompatibility was studied in vitro, and its characteristics of self-set and bioresorbability were investigated through canine bilateral humerus defect model.Results:The experiments demonstrated excellent remodeling of implanted material with full resorbtion at 12 to 18 weeks. Radiographic observations of healing fractures in clinical evaluation studies have confirmed that implant resorbtion and bone regeneration occur at a clinically acceptable rate. Conclusion:An injectable bioresorbable bone putty with adjustable hardening time is described. The performance characteristics of the putty meet the requirements for numerous bone augmentation procedures. The putty is self-setting, nearly isothermic, and can harden in situ even in wet or bloody environments. The components of the implant are designed to produce a neutral-pH putty that resembles bone hard tissue and do not contain polymers or plasticizers. Numerous in vitro studies demonstrate that the putty is highly biocompatible and non-pyrogenic.
出处 《中国现代医学杂志》 CAS CSCD 2003年第18期1-6,10,共7页 China Journal of Modern Medicine
关键词 纳米结晶羟基磷灰石 骨移植 骨替代 骨组织充填 注射型纳米骨浆 人造骨 生物体可吸收性 骨水泥 Nanocrystalline Hydroxyapatite Bone Graft Bone Substitute Bone Void Filler Injectable Nanobone Putty Synthetic Bone Bioresorbable Bone Cement
  • 相关文献

参考文献15

  • 1杨晓庆,李玉宝,魏杰,王学江,左奕.医用羟基磷灰石/二氧化钛纳米复合材料的制备及性能研究[J].中国现代医学杂志,2003,13(5):26-28. 被引量:12
  • 2Banwart JC, Asher MA, Hassanein RS. Iliac crest hone graft harvest donor site morbidity. A statistical evaluation. Spine, 1995;20(9): 1055-1060.
  • 3Begley CT, Doherty MJ, Mollan RA, et al. Comparative study of the osteoinductive properties of bioceramic, coral and processed bone graft substitutes. Biomaterials, 1995 ; 16(15) : 1181 - 1185.
  • 4Betz R R. Limitations of autograft and allograft: new synthetic solutions. Orthopedics, 2002;25(5 Suppl): s561-570.
  • 5Bucholz R W. Nonallograft osteoconductive bone graft substitutes.Clin Orthop,2002; (395) : 44-52.
  • 6Buck BE, Malinin TI. Human hone and tissue allografts. Preparation and safety. Clin Orthop, 1994; (303) : 8- 17.
  • 7Chow LC,Takagi S. A natural bone cement A laboratory novelty led to the development of revolutionary new biomaterials. J Res Natl Inst Stand Technol,2001 ; 106:1029-1033.
  • 8Daculsi G. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials,1998, 19(16) : 1473- 1478.
  • 9Hardin CK. Banked bone. Otolaryngol Clin North Am, 1994; 27(5) : 911 -9259.
  • 10Kelly CM, Wilkins RM,Gitelis S, et al. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop, 2001;(382): 42-50.

二级参考文献4

共引文献11

同被引文献312

引证文献22

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部